Almanack Investment Partners’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-188
Closed -$4K – 633
2022
Q3
$4K Buy
+188
New +$4.41K ﹤0.01% 626

Other funds holding IBD

Almanack Investment Partners's IBD Position: Q4 2022 in Review

Almanack Investment Partners sold out of Inspire Corporate Bond ETF (IBD) in Q4 2022, closing a stake of 188 shares — an estimated $4K sold.

Almanack Investment Partners first reported a position in IBD in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 51 funds tracked by Wall St. Rank hold IBD as of Q4 2022.

  • Almanack Investment Partners reported no remaining Inspire Corporate Bond ETF position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 188 Inspire Corporate Bond ETF shares in Q4 2022, an estimated $4K.
  • Almanack Investment Partners first reported a position in Inspire Corporate Bond ETF in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's Inspire Corporate Bond ETF position peaked at $4K in Q3 2022.
  • 51 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.